These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30081104)
1. Niclosamide ethanolamine improves kidney injury in db/db mice. Han P; Zhan H; Shao M; Wang W; Song G; Yu X; Zhang C; Ge N; Yi T; Li S; Sun H Diabetes Res Clin Pract; 2018 Oct; 144():25-33. PubMed ID: 30081104 [TBL] [Abstract][Full Text] [Related]
2. Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice. Han P; Shao M; Guo L; Wang W; Song G; Yu X; Zhang C; Ge N; Yi T; Li S; Du H; Sun H Am J Transl Res; 2018; 10(4):1071-1084. PubMed ID: 29736201 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. Hinder LM; Sas KM; O'Brien PD; Backus C; Kayampilly P; Hayes JM; Lin CM; Zhang H; Shanmugam S; Rumora AE; Abcouwer SF; Brosius FC; Pennathur S; Feldman EL Sci Rep; 2019 Jan; 9(1):881. PubMed ID: 30696927 [TBL] [Abstract][Full Text] [Related]
4. Niclosamide ethanolamine inhibits artery constriction. Li SL; Yan J; Zhang YQ; Zhen CL; Liu MY; Jin J; Gao JL; Xiao XL; Shen X; Tai Y; Hu N; Zhang XZ; Sun ZJ; Dong DL Pharmacol Res; 2017 Jan; 115():78-86. PubMed ID: 27872020 [TBL] [Abstract][Full Text] [Related]
6. Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice. Guo J; Tao H; Alasadi A; Huang Q; Jin S Eat Weight Disord; 2019 Feb; 24(1):91-96. PubMed ID: 28780747 [TBL] [Abstract][Full Text] [Related]
7. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Tao H; Zhang Y; Zeng X; Shulman GI; Jin S Nat Med; 2014 Nov; 20(11):1263-9. PubMed ID: 25282357 [TBL] [Abstract][Full Text] [Related]
8. Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance. Han P; Yuan C; Wang Y; Wang M; Weng W; Zhan H; Yu X; Wang T; Li Y; Yi W; Shao M; Li S; Yi T; Sun H Am J Transl Res; 2019; 11(2):855-864. PubMed ID: 30899385 [TBL] [Abstract][Full Text] [Related]
9. Repurposing Niclosamide to Modulate Renal RNA-Binding Protein HuR for the Treatment of Diabetic Nephropathy in db/db Mice. Zhuang L; Liu W; Tsai XQ; Outtrim C; Tang A; Wang Z; Huang Y Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273597 [TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224 [TBL] [Abstract][Full Text] [Related]
11. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway. Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C Cells; 2022 Jan; 11(3):. PubMed ID: 35159160 [TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. Lin Y; Sun Z J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121 [TBL] [Abstract][Full Text] [Related]
13. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes. Takenaka T; Kobori H; Miyazaki T; Suzuki H; Nishiyama A; Ishii N; Yamashita M; Hayashi M Acta Physiol (Oxf); 2019 Feb; 225(2):e13190. PubMed ID: 30251773 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes. El Boustany R; Taveau C; Chollet C; Velho G; Bankir L; Alhenc-Gelas F; Roussel R; Bouby N J Diabetes Complications; 2017 Jun; 31(6):929-932. PubMed ID: 28412033 [TBL] [Abstract][Full Text] [Related]
15. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526 [TBL] [Abstract][Full Text] [Related]
16. Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice. Han P; Weng W; Chen Y; Cai Y; Wang Y; Wang M; Zhan H; Yuan C; Yu X; Shao M; Sun H Am J Transl Res; 2020; 12(9):5015-5031. PubMed ID: 33042403 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350 [TBL] [Abstract][Full Text] [Related]
18. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677 [TBL] [Abstract][Full Text] [Related]
19. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686 [TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV ameliorates renal injury in db/db mice. Sun H; Wang W; Han P; Shao M; Song G; Du H; Yi T; Li S Sci Rep; 2016 Sep; 6():32545. PubMed ID: 27585918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]